Disclosed positions

Estimated from their latest filings — positions may have changed since

$9.36M

combined est. value

Stock	Shares	Price	Value	Weight	As of
AUPHAurinia Pharmaceuticals Inc.	576,421	$16.23	$9.36M	100%	2026-03-02

AUPH

Aurinia Pharmaceuticals Inc.

$9.36M

576,421 sh

All filings on record

Every Form 4 transaction we track for this filer

all 5buys 0sells 0

Stock	Transaction	Date	~6mo later
AUPHAurinia Pharmaceuticals Inc.	Tax $533.0K · 37,511 sh	2026-03-02	—
AUPHAurinia Pharmaceuticals Inc.	Grant — · 57,229 sh	2026-02-27	—
AUPHAurinia Pharmaceuticals Inc.	Tax $466.9K · 32,424 sh	2026-02-20	—
AUPHAurinia Pharmaceuticals Inc.	Tax $640.6K · 40,161 sh	2026-01-02	—
AUPHAurinia Pharmaceuticals Inc.	Grant — · 49,038 sh	2026-01-02	—

AUPHTax

2026-03-02 · Aurinia Pharmaceuticals Inc.

$533.0K

—

AUPHGrant

2026-02-27 · Aurinia Pharmaceuticals Inc.

57,229

—

AUPHTax

2026-02-20 · Aurinia Pharmaceuticals Inc.

$466.9K

—

AUPHTax

2026-01-02 · Aurinia Pharmaceuticals Inc.

$640.6K

—

AUPHGrant

2026-01-02 · Aurinia Pharmaceuticals Inc.

49,038

—

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.